The Expression level of hypoxia inducible factor 1α gene in psoriatic patients in Suez Canal region
HIF1α
DOI:
https://doi.org/10.66344/jpad.v31i4.1741Abstract
Objective To compare the expression of the HIF-1α gene in patients with psoriasis to that of healthy controls to assess the role of the HIF-1α gene in the initiation, progression and severity of psoriasis.
Methods A case–control study with 36 patients with psoriasis and 36 healthy controls was conducted. Blood samples were taken from both the patients and controls. For both groups, the relative expression of the HIF-1α gene will be evaluated using the polymerase chain reaction (PCR) technique.
Results PASI scores ranged from 2–34. Eighteen patients (50%) had mild psoriasis, 9 patients (25%) had moderate psoriasis and 9 patients (25%) had severe psoriasis. Only 6 patients (16.7%) had a family history of psoriasis. The mean BMI for population with psoriasis was 24.06±3.18. The control group matched the psoriasis group regarding age and gender. The mean relative HIF-1α expression levels of the psoriatic and control groups were 3.38±1.87 and 1.0±0.0, respectively. There was a significant increase in the HIF-1α gene expression in patients with psoriasis compared with controls and that expression level significantly increased with psoriasis severity.
Conclusion HIF-1α expression level was significantly higher in patients with psoriasis compared to healthy controls, implying its role throughout psoriasis pathogenesis.
References
1. Ryan C and Kirby B. Psoriasis Is a Systemic Disease with Multiple Cardiovascular and Metabolic Comorbidities. Dermatol Clin.2015;33(1):41-55.
2. Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol.2017;76(3):377-90.
3. DiBonaventura, M., Carvalho, A. V. E. D., Souza, C. D. S., Squiassi, H. B., & Ferreira, C. N. The association between psoriasis and health-related quality of life, work productivity, and healthcare resource use in Brazil. Anais Brasileiros de Dermatologia.2018;93(2):197-204.
4. Bronckers, I., Paller, A., Van Geel, M., Van De Kerkhof, P. & Seyger, M. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Pediatr Drugs.2017;17:373-84.
5. Xu, X. & Zhang, H.-Y. The Immunogenetics of Psoriasis and Implications for Drug Repositioning. Int J Mol Sci.2017;18:2650.
6. Reich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., Griffiths, C. E. & Investigators, E. S. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. The Lancet.2005;366:1367-74.
7. Rosenberg, C., Solovan, C., Rosenberger, A. D., Jinping, L., Treudler, R., Frei, U., Eckardt, K.U., & Brown, L. F. Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J Invest Dermatol.2007;127(10):2445-52.
8. Kim, W. B., Jerome, D. & Yeung, J. Diagnosis and management of psoriasis. Can Fam Physician.2017;63:278-85.
9. Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer.2003;3(10):721.
10. Koshiji, M., To, K. K.-W., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P. & Huang, L. E. HIF-1α induces genetic instability by transcriptionally downregulating MutSα expression. Mol Cell.2005;17:793-803.
11. Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. Immunology of psoriasis. Annu Review Immunol.2014;32:227-55.
12. Houshang, N., Reza, K., Masoud, S., Ali, E., Mansour, R. & Vaisi-Raygani, A. Antioxidant status in patients with psoriasis. Cell Biochem Funct.2014;32:268-73.
13. Yu, C. S. Study on HIF-1α gene translation in psoriatic epidermis with the topical treatment of capsaicin ointment. ISRN Pharm.2011;2011:821874.
14. Hagg, D., Sundström, A., Eriksson, M., & Schmitt-Egenolf, M. Severity of psoriasis differs between men and women: a study of the clinical outcome measure psoriasis area and severity index (PASI): in 5438 Swedish register patients. Am J Clin Dermatol.2017;18(4):583-90.
15. Robinson, A., Van Voorhees, A. S., Hsu, S., Korman, N. J., Lebwohl, M. G., Bebo Jr, B. F., & Kalb, R. E. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol.2012;67(2):279-88.
16. Erices, A., Conget, P., & Minguell, J. J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol;2000; 109(1):235-42.
17. Nijsten, T., & Wakkee, M. Complexity of the association between psoriasis and comorbidities. J Invest Dermatol.2009;129(7):1601-3.
18. Ioannou, M., Sourli, F., Mylonis, I., Barbanis, S., Papamichali, R., Kouvaras, E., & Roussaki-Schulze, A. V. Increased HIF-1 alpha immunostaining in psoriasis compared to psoriasiform dermatitides. J Cut Pathol;2009:36(12):1255-61.
19. Yongjian LI, Guiying Z, Rong X, Huan C and Haiquan W. Expression of iNOS and HIF-1α with angiogenesis in affected skin biopsies from patients with psoriasis. J Cent Sount Univ.2010;35(9):952-6.
20. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci.2000;24(1):S78–8.
21. Xia, Y. P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D., & Rudge, J. S. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood.2003;102(1):161-8.
22. Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol.2000;158:1145–60
23. Nakamura H, Makino Y, Okamoto K, Poellinger L and Morimoto C. TCR engagement increases hypoxia-inducible factor-1 alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J Immunol.2005;174:7592–9
24. Haddad JJ and Harb HL. Cytokines and the regulation of the hypoxiainducible factor (HIF):-1a. Int Immunopharmacol5:461–8
25. Lowes MA, Bowcock AM and Krueger JG (2007): Pathogenesis and therapy of psoriasis. Nature.2005;445:866.
26. Vasillopolus, Y., Sourli, F., Zafiriou, E., Klimi, E., Ioannou, M., Mamuris, Z., & Roussaki-Schulze, A. High serum levels of HIF-1α in psoriatic patients correlate with an over-expression of IL-6. Cytokine.2013; 62(1):38-9.
27. Tovar-Castillo, L. E., Cancino-Díaz, J. C., García-Vázquez, F., Cancino-Gómez, F. G., León-Dorantes, G., Blancas-González, F., Jiménez-Zamudio, L., García-Latorre, E., &Cancino-Díaz, M. E. Under-expression of VHL and over-expression of HDAC-1, HIF-1α, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis. Int J Dermatol.2007;46(3):239-46.
28. Tao, J., Yang, J., Wang, L., Li, Y., Liu, Y. Q., Dong, J., L., Wen, X., Shen, G.X., &Tu, Y. T. Expression of GLUT-1 in psoriasis and the relationship between GLUT-1 upregulation induced by hypoxia and proliferation of keratinocyte growth. J Dermatol Sci.2008;51(3):203-7.
29. Li, Y.; Su, J.; Li, F.; Chen, X.; Zhang, G. MiR-150 Regulates Human Keratinocyte Proliferation in Hypoxic Conditions through Targeting HIF-1α and VEGFA: Implications for Psoriasis Treatment. PloS One.2017;12(4):e0175459.
DOI: 10.1371/journal.pone.0175459.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Eman Khalil, Amal Gomaa, Nader Ismail, Noha Abd El fadeal, Ghada Mohammed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
